Skip to Content

Floxuridine Pregnancy and Breastfeeding Warnings

Floxuridine is also known as: FUDR

Floxuridine Pregnancy Warnings

This drug should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. US FDA pregnancy category: D

Animal studies have revealed evidence of teratogenicity. Malformations have included cleft palates, skeletal defects, and deformed appendages, paws, and tails. There are no controlled data in human pregnancy. No cases of human teratogenicity due to this drug have been reported. However, human teratogenicity has been reported with the use of drugs which inhibit DNA synthesis such as fluorouracil, methotrexate, and aminopterin. Floxuridine is catabolized to fluorouracil. The use of intravenous fluorouracil in the first trimester resulted in multiple defects (radial aplasia; absent thumbs and fingers; hypoplasia of lungs, aorta, thymus, and bile duct; aplasia of esophagus, duodenum, and ureters; single umbilical artery; absent appendix; imperforate anus; a cloaca) in an aborted fetus. Other toxicities reported include cyanosis and jerking extremities in a newborn exposed to fluorouracil in the third trimester. Fluorouracil has been reported to induce chromosomal aberrations and changes in chromosome organization of spermatogonia in animals. Spermatogonial differentiation was also inhibited by fluorouracil, resulting in transient infertility in animals. US FDA pregnancy category D: There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

See references

Floxuridine Breastfeeding Warnings

Use is not recommended. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comment: This drug has the potential to harm a nursing infant because it inhibits DNA and RNA synthesis.

See references

References for pregnancy information

  1. Stephens JD, Golbus MS, Miller TR, Wilber RR, Epstein CJ "Multiple congenital anomalies in a fetus exposed to 5-fluorouracil during the first trimester." Am J Obstet Gynecol 137 (1980): 747-9
  2. Dreicer R, Love RR "High total dose 5-fluorouracil treatment during pregnancy." Wis Med J 90 (1991): 582-3
  3. Stadler HE, Knowles J "Fluorouracil in pregnancy: effect on the neonate." JAMA 217 (1971): 214-5
  4. "Product Information. Fluorouracil injection (fluorouracil)." Roche Laboratories, Nutley, NJ.
  5. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):
  6. Sutton R, Buzdar AU, Hortobagyi GN "Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients." Cancer 65 (1990): 847-50
  7. "Product Information. FUDR Sterile (floxuridine)." Roche Laboratories, Nutley, NJ.

References for breastfeeding information

  1. "Product Information. FUDR Sterile (floxuridine)." Roche Laboratories, Nutley, NJ.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.